If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPolar Capital Regulatory News (POLR)

Share Price Information for Polar Capital (POLR)

Share Price is delayed by 15 minutes
Get Live Data
918.00    -23.00 (-2.44%)
Bid:
913.00
Ask:
915.00
Spread: 2.00 (0.219%)
Market Cap: £864.63m
POLR Live PriceLast checked at - London Stock Exchange

Intraday Polar Capital Share Chart

Director/PDMR Shareholding

22 Jan 2010 14:50

RNS Number : 0113G
Polar Capital Holdings PLC
22 January 2010
 

22 January 2010

Polar Capital Holdings plc ("Polar Capital" or the "Company")

Director's Dealings - Award of Share Options as Equity Settled Share Appreciation Rights ("ESARs")

Polar Capital announces that, on 22 January 2010John Mansell, the Chief Operating Officer of the Company, was granted share option over a total of 1,000,000 ordinary shares of 2.5p each in the Company at an exercise price per share of  91.5p per share ("the Option").

The Option is not subject to any performance conditions and will become exercisable as to one third on each of the vesting dates, being 31 March 2012, 31 March 2013 and 31 March 2014.

The Option is subject to the requirement that in order to be able to exercise the Option, the Option holder must be employed by the Company on the relevant vesting date, subject to certain defined "good leaver" situations. 

The Option will lapse unless exercised within 10 years from the date of grant.

The Option will be satisfied in accordance with the rules of the Polar Capital Equity Incentive Plan, by the use of the provisions relating to Equity Settled Share Appreciation Rights ("ESARs"). The use of the ESARs provisions allows the Company to issue to the option holder only the number of shares that would equate to the number of shares over which the option becomes exercisable less the number of shares that would need to be sold to fund the purchase of that number of shares on that exercise date.

For further information please contact:

Polar Capital

Tim WoolleyJohn Mansell

+44 (0)20 7227 2700

Numis Securities

Simon Blank (Nominated Adviser)

Charles Farquhar (Corporate Broking)

+44 (0)20 7260 1000

Financial Dynamics 

Ed Gascoigne-Pees

Georgina Turner

+44 (0)20 7269 7132

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSZLLFLBFFZBBD
Date   Source Headline
4th Mar 20259:44 amRNSHolding(s) in Company
3rd Feb 20253:34 pmRNSBlock listing Interim Review
28th Jan 20259:33 amRNSDirector/PDMR Shareholding
22nd Jan 20252:05 pmRNSHolding(s) in Company
22nd Jan 20251:44 pmRNSDirector/PDMR Shareholding
17th Jan 202511:07 amRNSDirector/PDMR Shareholding
16th Jan 20252:43 pmRNSForm 8.3 - Direct Line Insurance Group PLC
15th Jan 20252:24 pmRNSForm 8.3 - Direct Line Insurance Group PLC
14th Jan 20254:28 pmRNSForm 8.3 - Direct Line Group PLC
13th Jan 20257:00 amRNSAuM Update
24th Dec 202410:36 amRNSForm 8.3 - Direct Line Insurance Group PLC
23rd Dec 20245:11 pmRNSForm 8.3 - Intelligent Ultrasound Group PLC Amend
23rd Dec 202412:20 pmRNSForm 8.3 - Intelligent Ultrasound Group PLC
2nd Dec 202411:43 amRNSTotal Voting Rights
29th Nov 20244:54 pmRNSForm 8.3 - Direct Line Insurance Group PLC
26th Nov 202410:02 amRNSHolding(s) in Company
18th Nov 20247:00 amRNSUnaudited Interim Results
12th Nov 20249:14 amRNSCrystallisation of Business Unit & Issue of Shares
31st Oct 20247:00 amRNSNotice of Results
10th Oct 20247:00 amRNSAuM Update
26th Sep 20243:54 pmRNSReplacement: Result of AGM
25th Sep 20243:43 pmRNSResult of AGM
16th Aug 20242:08 pmRNSForm 8.3 - RENALYTIX PLC
15th Aug 202412:37 pmRNSForm 8.3 - RENALYTIX PLC
13th Aug 20243:08 pmRNSForm 8.3 - RENALYTIX PLC
5th Aug 20241:44 pmRNSBlock listing Interim Review
1st Aug 20249:16 amRNSDirector/PDMR Shareholding
22nd Jul 20244:53 pmRNSDirector/PDMR Shareholding
18th Jul 20244:56 pmRNSHolding(s) in Company
15th Jul 202411:04 amRNSDirector/PDMR Shareholding
11th Jul 20249:49 amRNSForm 8.3 - CREST NICHOLSON HOLDINGS PLC
11th Jul 20247:00 amRNSAuM Update
4th Jul 20246:23 pmRNSDirector/PDMR Shareholding
2nd Jul 20245:05 pmRNSHolding(s) in Company
27th Jun 20241:15 pmRNSGroup Audited Results for year ended 31 March 2024
27th Jun 20247:00 amRNSGroup Audited Results for year ended 31 March 2024
17th Jun 20243:37 pmRNSForm 8.3 - CREST NICHOLSON HOLDINGS
3rd Jun 20246:16 pmRNSTotal Voting Rights
3rd Jun 20241:56 pmRNSTotal Voting Rights
22nd May 20249:12 amRNSIssue of Equity
15th May 202410:06 amRNSDirector/PDMR Shareholding
13th May 20245:49 pmRNSHolding(s) in Company
13th May 20243:34 pmRNSHolding(s) in Company
26th Apr 202410:33 amRNSForm 8.3 - RENALYTIX PLC
17th Apr 20243:55 pmRNSDirector/PDMR Shareholding
12th Apr 20245:43 pmRNSHolding(s) in Company
11th Apr 20247:00 amRNSAuM Update
9th Apr 20244:01 pmRNSChange of Company Secretary
15th Mar 20243:02 pmRNSForm 8.3 - Renalytix PLC
15th Mar 202410:23 amRNSForm 8.3 - Renalytix PLC - Replacement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.